These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 20831495)
21. Helical tomotherapy-based STAT RT: Dosimetric evaluation for clinical implementation of a rapid radiation palliation program. McIntosh A; Dunlap N; Sheng K; Geezey C; Turner B; Blackhall L; Weiss G; Lappinen E; Larner JM; Read PW Med Dosim; 2010; 35(4):280-6. PubMed ID: 19944589 [TBL] [Abstract][Full Text] [Related]
22. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339 [TBL] [Abstract][Full Text] [Related]
23. Radiobiological and dosimetric analysis of daily megavoltage CT registration on adaptive radiotherapy with Helical Tomotherapy. Mavroidis P; Su FC; Giantsoudi D; Stathakis S; Komisopoulos G; Shi C; Swanson G; Papanikolaou N Technol Cancer Res Treat; 2011 Feb; 10(1):1-13. PubMed ID: 21214283 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the 3D-conformal, helical tomotherapy and multileaf collimators-based intensity modulated radiotherapy modalities using radiobiological measures. Mavroidis P; Costa Ferreira B; Shi C; Lind BK; Papanikolaou N J BUON; 2008; 13(1):75-86. PubMed ID: 18404791 [TBL] [Abstract][Full Text] [Related]
25. Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer. Christian JA; Bedford JL; Webb S; Brada M Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):735-41. PubMed ID: 17187941 [TBL] [Abstract][Full Text] [Related]
26. Critical dose and toxicity index of organs at risk in radiotherapy: analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer. Pedicini P; Strigari L; Benassi M; Caivano R; Fiorentino A; Nappi A; Salvatore M; Storto G Med Dosim; 2014; 39(1):23-30. PubMed ID: 24239409 [TBL] [Abstract][Full Text] [Related]
27. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review. Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445 [TBL] [Abstract][Full Text] [Related]
28. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters. Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066 [TBL] [Abstract][Full Text] [Related]
29. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience. Henkenberens C; Janssen S; Lavae-Mokhtari M; Leni K; Meyer A; Christiansen H; Bremer M; Dickgreber N Radiat Oncol; 2016 Feb; 11():12. PubMed ID: 26830686 [TBL] [Abstract][Full Text] [Related]
30. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy]. Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300 [TBL] [Abstract][Full Text] [Related]
32. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242 [TBL] [Abstract][Full Text] [Related]
33. [Therapeutic efficacy of three-dimensional conformal radiation therapy for patients with locally advanced non-small cell lung cancer]. Cao JZ; Ou GF; Liang J; Lü JM; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang LH; Yin WB Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):529-34. PubMed ID: 22093633 [TBL] [Abstract][Full Text] [Related]
34. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Kong FM; Hayman JA; Griffith KA; Kalemkerian GP; Arenberg D; Lyons S; Turrisi A; Lichter A; Fraass B; Eisbruch A; Lawrence TS; Ten Haken RK Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1075-86. PubMed ID: 16647222 [TBL] [Abstract][Full Text] [Related]
35. Clinical three-dimensional conformal radiotherapy research using repeated computed tomography scans for field reduction in older non-small-cell lung cancer patients. Fu ZZ; Gu T; Zhang SH; Cao XY; Zhang QH; Zhang YQ; Hua HX; Yang S; Li P; Zhang Z Genet Mol Res; 2014 Jul; 13(3):5343-9. PubMed ID: 25078590 [TBL] [Abstract][Full Text] [Related]
36. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548 [TBL] [Abstract][Full Text] [Related]
37. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer]. Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623 [TBL] [Abstract][Full Text] [Related]
38. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067 [TBL] [Abstract][Full Text] [Related]
39. Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatments. Diot Q; Marks LB; Bentzen SM; Senan S; Kavanagh BD; Lawrence MV; Miften M; Palma DA Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):626-32. PubMed ID: 24929168 [TBL] [Abstract][Full Text] [Related]
40. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]